| JFLJX | OCGCX | JFLJX / OCGCX | |
| Total Expense Ratio | 0.43 | 1.42 | 30% |
| Annual Report Gross Expense Ratio | 0.43 | 1.42 | 30% |
| Fund Existence | 9 years | 29 years | - |
| Gain YTD | 2.989 | 2.427 | 123% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 15000000 | 500 | 3,000,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.36B | 4.36B | 100% |
| Annual Yield % from dividends | 3.70 | 2.75 | 135% |
| Returns for 1 year | 6.62 | 5.56 | 119% |
| Returns for 3 years | 23.90 | 20.24 | 118% |
| Returns for 5 years | 11.33 | 6.03 | 188% |
| Returns for 10 years | N/A | 27.30 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ODVIX | 39.97 | 0.70 | +1.78% |
| Invesco Developing Markets R6 | |||
| AXVIX | 22.21 | -0.04 | -0.18% |
| Acclivity Small Cap Value I | |||
| ATGDX | 13.95 | -0.09 | -0.64% |
| American Century International Gr R6 | |||
| ERHSX | 14.60 | -0.17 | -1.15% |
| Eaton Vance Worldwide Health Sci R | |||
| MSSMX | 10.76 | -0.13 | -1.19% |
| Morgan Stanley Inst Inception A | |||